TRX518

· Leap Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TRX518, covering 2025-08-03 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors [Phase 1]